Related Experiment Video
Updated: Aug 12, 2026

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different
Bispecific monoclonal antibodies (BSMAB) can target cells expressing two antigens, enhancing immunotherapeutic selectivity. These novel antibodies demonstrate significantly improved complement-mediated lysis of dual-antigen-positive cells.
Area of Science:
- Immunology
- Biotechnology
- Cell Biology
Background:
- Immunotherapy aims for targeted cell destruction.
- Distinguishing cells co-expressing multiple antigens is a challenge.
- Bispecific monoclonal antibodies (BSMAB) offer potential for enhanced selectivity.
Purpose of the Study:
- To develop and characterize BSMAB targeting T cell surface antigens.
- To evaluate the efficacy of BSMAB in complement-mediated lysis.
- To investigate the mechanism of enhanced selectivity.
Main Methods:
- Hybrid-hybridoma technology for BSMAB production.
- Isoelectric focusing for antibody purification.
- Flow cytometry for surface antigen detection.
- Complement-mediated cytotoxicity assays.
Main Results:
- Two BSMAB, CD3,4 and CD3,8, were successfully produced.
- BSMAB demonstrated 25-3125 fold greater efficiency in lysing dual-antigen target cells.
- Increased antibody avidity and surface immunoglobulin concentration correlated with enhanced lysis.
- A threshold surface immunoglobulin density was identified for effective complement fixation.
Conclusions:
- BSMAB can achieve high selectivity by targeting co-expressed antigens.
- Enhanced avidity is key to BSMAB's improved cytotoxic potential.
- Results support the associative model of IgG-mediated complement fixation.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
13:14Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
Related Concept Videos
Cross-reactivity
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Hypersensitivity Reactions: Cytolytic Reactions